Acquired resistance to anti-EGFR mAb ICR62 or afatinib is accompanied by upregulation of the EGFR in colorectal cancer

    Research output: Contribution to conferencePaperpeer-review

    Original languageEnglish
    DOIs
    Publication statusPublished - Apr 2013
    Event104th Annual Meeting of the American Association for Cancer Research - Washington, U.S.A.
    Duration: 6 Apr 201310 Apr 2013

    Conference

    Conference104th Annual Meeting of the American Association for Cancer Research
    Period6/04/1310/04/13

    Bibliographical note

    Organising Body: American Association for Cancer Research

    Keywords

    • Cancer studies

    Cite this